Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | +1.96% | -9.57% | +17.34% |
Sales 2024 * | 155M 212M | Sales 2025 * | 169M 231M | Capitalization | 103M 141M |
---|---|---|---|---|---|
Net income 2024 * | -142M -194M | Net income 2025 * | -102M -139M | EV / Sales 2024 * | 0.67 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.61 x |
P/E ratio 2024 * |
-0.73
x | P/E ratio 2025 * |
-1.04
x | Employees | 486 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.08% |
Latest transcript on FibroGen, Inc.
1 day | +1.96% | ||
1 week | -9.57% | ||
Current month | -55.74% | ||
1 month | -59.69% | ||
3 months | +11.12% | ||
6 months | +118.44% | ||
Current year | +17.34% |
Managers | Title | Age | Since |
---|---|---|---|
Thane Wettig
CEO | Chief Executive Officer | 59 | 20-06-21 |
Juan Graham
DFI | Director of Finance/CFO | 48 | 21-09-06 |
James Schoeneck
CHM | Chairman | 66 | 10-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Edwards
BRD | Director/Board Member | 64 | 15-10-27 |
Director/Board Member | 59 | 15-08-05 | |
May Kin Ho
BRD | Director/Board Member | 71 | 18-12-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.83% | 1 M€ | -5.79% | - | |
0.13% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.04 | +1.96% | 653,815 |
24-04-25 | 1.02 | +3.63% | 1,259,232 |
24-04-24 | 0.9843 | -8.01% | 2,170,507 |
24-04-23 | 1.07 | -6.14% | 1,349,229 |
24-04-22 | 1.14 | -0.87% | 803,876 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.34% | 103M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- FGEN Stock